Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.45
+0.37006.09%
Post-market: 6.450.00000.00%16:00 EDT
Volume:18.12K
Turnover:118.21K
Market Cap:548.46M
PE:-5.53
High:6.73
Open:6.53
Low:6.16
Close:6.08
Loading ...

Europe's Medicines Agency Lifts Temporary Age Restriction on Valneva's Chikungunya Vaccine

MT Newswires Live
·
11 Jul

Press Release: Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Dow Jones
·
25 Jun

European Equities Traded in the US as American Depositary Receipts Edge Higher Monday

MT Newswires Live
·
09 Jun

Valneva drops 2% to $6.05 after UK restricts vaccine use

TIPRANKS
·
09 Jun

Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years

TIPRANKS
·
05 Jun

Press Release: Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Dow Jones
·
04 Jun

Valneva Is Maintained at Buy by Guggenheim

Dow Jones
·
08 May

Valneva price target lowered to $14 from $15 at Guggenheim

TIPRANKS
·
08 May

Valneva Q1 EPS $(0.13) Beats $(0.20) Estimate, Sales $51.77M Beat $40.20M Estimate

Benzinga
·
07 May

Valneva SE reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Valneva Reaffirms 2025 Outlook: Sales Revenue Projected At €170M-€180M, Total Revenue To Reach €180M-€190M; R&D Investments Of €90M-€100M

Benzinga
·
07 May

Valneva Q1 Sales $51.23M Beat $40.20M Estimate, Net Loss $9.675M

Benzinga
·
07 May

Valneva SE expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
05 May

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Valneva (VALN) and BridgeBio Pharma (BBIO)

TIPRANKS
·
29 Apr

Valneva's Chikungunya Vaccine Ixchiq Suspended for Elderly in France

MT Newswires Live
·
28 Apr

Valneva Shares Slump After France Suspends Chikungunya Vaccine for Elderly

Dow Jones
·
28 Apr

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

GlobeNewswire
·
16 Apr

Valneva Gets Marketing Authorization for IXCHIQ Vaccine in Brazil

MT Newswires Live
·
15 Apr

Valneva granted marketing authorization for Ixchiq in Brail

TIPRANKS
·
14 Apr

Valneva Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Apr